Communicable Diseases Book by MR Daniel Karani
Communicable Diseases Book by MR Daniel Karani
Communicable Diseases Book by MR Daniel Karani
Communicable Disease
Control
Mulugeta Alemayehu
Hawassa University
In collaboration with the Ethiopia Public Health Training Initiative, The Carter Center,
the Ethiopia Ministry of Health, and the Ethiopia Ministry of Education
2004
Funded under USAID Cooperative Agreement No. 663-A-00-00-0358-00.
Produced in collaboration with the Ethiopia Public Health Training Initiative, The Carter
Center, the Ethiopia Ministry of Health, and the Ethiopia Ministry of Education.
All rights reserved. Except as expressly provided above, no part of this publication may
be reproduced or transmitted in any form or by any means, electronic or mechanical,
including photocopying, recording, or by any information storage and retrieval system,
without written permission of the author or authors.
This material is intended for educational use only by practicing health care workers or
students and faculty in a health care field.
Communicable Disease Control
Preface
i
Communicable Disease Control
ii
Communicable Disease Control
Acknowledgments
iii
Communicable Disease Control
Table of Contents
Preface i
Acknowledgement iii
Table of Contents iv
List of Figures ix
Abbreviations and Acronyms x
iv
Communicable Disease Control
v
Communicable Disease Control
5.2 Introduction 92
5.3 Mosquito-borne Diseases 93
5.4 Flea-borne Diseases 106
5.5 Louse-borne Diseases 111
5.6 Snail-borne Diseases 116
Review Questions 126
vi
Communicable Disease Control
Glossary 206
References 211
vii
Communicable Disease Control
List of Figures
viii
Communicable Disease Control
ix
Communicable Disease Control
x
Communicable Disease Control
CHAPTER ONE
INTRODUCTION
1.1 Learning Objectives
At the end of this chapter, the student will be able to:
- Describe the burden of communicable diseases in
Ethiopia.
- Define epidemiology and epidemiological terminologies.
- Identify the major communicable diseases that pose
health problems in Ethiopia.
1
Communicable Disease Control
During the past 70 years, there has been a dramatic fall in the
incidence of infectious diseases, particularly in developed
countries. This is due to severeal factors including:
Immunization
2
Communicable Disease Control
Anti-microbial chemotherapy
Improved nutrition
Better sanitation and housing
3
Communicable Disease Control
- Pneumonia (8.9%)
- Tuberculosis of respiratory system (7.8%)
- Bacillary dysentery (1.6%)
- Gastroenteritis and colitis (1.5%)
- Meningitis (0.9%)
The top leading causes of deaths were:
- Tuberculosis of the respiratory system (10.1%)
- Pneumonia (7.3%)
- All types of malaria (4.6%)
- Bacillary dysentery (2.2%)
- Meningitis (1.5%)
- Gastroenteritis and colitis (1.1%)
- AIDS (0.8%)
- Leishmaniasis (0.5%)
4
Communicable Disease Control
5
Communicable Disease Control
6
Communicable Disease Control
Review Questions
7
Communicable Disease Control
CHAPTER TWO
8
Communicable Disease Control
9
Communicable Disease Control
Types of reservoirs
1. Man: There are a number of important pathogens that are
specifically adapted to man, such as: measles, smallpox,
typhoid, meningococcal meningitis, gonorrhea and syphilis.
The cycle of transmission is from human to human.
10
Communicable Disease Control
11
Communicable Disease Control
a. Direct Vertical
Such as: transplacental transmission of syphilis, HIV, etc.
b. Direct horizontal
Direct touching, biting, kissing, sexual intercourse, droplet
spread onto the conjunctiva or onto mucus membrane of
eye, nose or mouth during sneezing coughing, spitting or
talking; Usually limited to a distance of about one meter or
less.
2. Indirect transmission
a. Vehicle-borne transmission: Indirect contact through
contaminated inanimate objects (fomites) like:
Bedding, toys, handkerchiefs, soiled clothes, cooking or
eating utensils, surgical instruments.
Contaminated food and water
Biological products like blood, serum, plasma or IV-fluids
or any substance serving as intermediate means by which
an infectious agent is transported and introduced into a
susceptible host through a suitable portal of entry. The
agent may or may not multiply or develop in the vehicle
before it is introduced into man.
12
Communicable Disease Control
13
Communicable Disease Control
GIT
Blood
14
Communicable Disease Control
15
Communicable Disease Control
16
Communicable Disease Control
17
Communicable Disease Control
18
Communicable Disease Control
19
Communicable Disease Control
20
Communicable Disease Control
2. Interruption of transmission
This involves the control of the modes of transmission from
the reservoir to the potential new host through:
Improvement of environmental sanitation and personal
hygiene
Control of vectors
Disinfections and sterilization
21
Communicable Disease Control
Review Questions
22
Communicable Disease Control
CHAPTER THREE
ORAL-FECAL TRANSMITTED
DISEASES
3.2 Introduction
23
Communicable Disease Control
Fig. 3.1 The five “Fs” which play an important role in fecal oral diseases
transmission (finger, flies, food, fomites and fluid). (From Eshuis,
Manschot,1978, Communicable Diseases: A Manual for Rural Health
Workers, African Medical and Research Association, Nairobi, Kenya)
24
Communicable Disease Control
Definition
A systemic infectious disease characterized by high
continuous fever, malaise and involvement of lymphoid
tissues.
Infectious agent
Salmonella typhi
Salmonella enteritidis (rare cause)
Epidemiology
Occurrence- It occurs worldwide, particularly in poor socio-
economic areas. Annual incidence is estimated at about 17
million cases with approximately 600,000 deaths worldwide. In
endemic areas the disease is most common in preschool and
school aged children (5-19 years of age).
Reservoir- Humans
25
Communicable Disease Control
Clinical manifestation
First week- Mild illness characterized by fever rising stepwise
(ladder type), anorexia, lethargy, malaise and general aches.
Dull and continuous frontal headache is prominent. Nose
bleeding, vague abdominal pain and constipation in 10% of
patients.
26
Communicable Disease Control
Diagnosis
Based on clinical grounds but this is confused with wide
variety of diseases.
Widal reaction against somatic and flagellar antigens.
Blood, feces or urine culture.
Treatment
1. Ampicillin or co-trimoxazole for carriers and mild cases.
2. Chloramphenicol or ciprofloxacin or ceftriaxone for
seriously ill patients.
27
Communicable Disease Control
Nursing care
1. Maintain body temperature to normal.
2. Apply comfort measures.
3. Follow side effects of drugs.
4. Monitor vital signs.
5. Follow strictly enteric precautions:
wash hands
wear gloves
teach all persons about personal hygiene
6. Observe the patient closely for sign and symptoms of
bowel perforation
erosion of intestinal ulcers
sudden pain in the lower right side of the abdomen
abdominal rigidity
sudden fall of temperature and blood pressure
7. Accurately record intake and output.
8. Provide proper skin and mouth care.
28
Communicable Disease Control
Definition
An acute bacterial disease involving the large and distal small
intestine, caused by the bacteria of the genus shigella.
Infectious agent
Shigella is comprised of four species or serotypes.
Group A= Shigella dysentraie (most common cause)
Group B= Shigella flexneri
Group C= Shigella boydii
Group D= Shigella sonnei
Epidemiology
Occurrence- It occurs worldwide, and is endemic in both
tropical and temperate climates. Outbreaks commonly occur
under conditions of crowding and where personal hygiene is
poor, such as in jails, institutions for children, day care
29
Communicable Disease Control
Reservoir- Humans
30
Communicable Disease Control
Clinical Manifestation
Fever, rapid pulse, vomiting and abdominal cramp are
prominent.
Diarrhea usually appears after 48 hours with dysentery
supervening two days later.
Generalized abdominal tenderness.
Tenesmus is present and feces are bloody, mucoid and of
small quantity.
Dehydration is common and dangerous - it may cause
muscular cramp, oliguria and shock.
Diagnosis
Based on clinical grounds
Stool microscopy (presence of pus cells)
Stool culture confirms the diagnosis
Treatment
1. Fluid and electrolyte replacement
2. Co-trimoxazole in severee cases or Nalidixic acid in the
case of resistance.
31
Communicable Disease Control
Definition
An infection due to a protozoan parasite that causes intestinal
or extra-intestinal disease.
Infectious agent
Entamoeba histolytica
Epidemiology
Occurrence- worldwide but most common in the tropics and
sub-tropics. Prevalent in areas with poor sanitation, in mental
institutions and homosexuals. Invasive amoebiasis is mostly a
disease of young people (adults). Rare below 5 years of age,
especially below 2 years.
32
Communicable Disease Control
Life cycle
TRANSMISSION
1. Cysts ingested in food, water
or from hands contaminated with
feces.
ENVIRONMENT
6. Feces containing infective cysts
contaminate the environment.
HUMAN HOST
2. cysts excyst, forming
trophozoites
3. Multiply in intestine
4. Trophozoites encyst.
5. Infective cysts passed in
feces.*
* trophozoites passed in feces
disintegrate.
Fig. 3.2 Transmission and life cycle of Entamoeba histolytica. (From Monica
Chesbrough, 1998, District Laboratory Practice in Tropical Countries, Part
One, Cambridge University Press, London.)
33
Communicable Disease Control
Clinical Manifestation
Starts with a prodormal episode of diarrhea, abdominal
cramps, nausea, vomiting and tenesmus.
With dysentery, feces are generally watery, containing
mucus and blood.
Diagnosis
Demonstration of etamoeba histolytica cyst or trophozoite
in stool.
Treatment
1. Metronidazole or Tinidazole
3.3.4 Giardiasis
Definition
A protozoan infection principally of the upper small intestine
associated with symptoms of chronic diarrhea, steatorrhea,
34
Communicable Disease Control
Infectious agent
Giardia lamblia
Epidemiology
Occurrence- Worldwide distribution. Children are more
affected than adults. The disease is highly prevalent in areas
of poor sanitation.
Reservoir- Humans
Mode of transmission- Person to person transmission
occurs by hand to mouth transfer of cysts from feces of an
infected individual especially in institutions and day care
centers.
35
Communicable Disease Control
Life cycle
TRANSMISSION
1. Cysts ingested in food,
water or from hands
contaminated with feces.
ENVIRONMENT
6. Feces containing
infective cysts
contaminate the
environment.
HUMAN HOST
2. cysts excyst,
forming
trophozoites
3. Multiply in intestine
4. Trophozoites
encyst.
5. Infective cysts
passed in feces. *
* trophozoites passed in feces
disintegrate.
Fig. 3.3 Transmission and Life Cycle of Giardia Lamblia. (From Monica
Chesbrough, 1998, District Laboratory Practice in Tropical Countries, Part
One, Cambridge University Press, London.)
Clinical Manifestation
Ranges from asymptomatic infection to severe failure to
thrive and mal-absorption.
Young children usually have diarrhea but abdominal
distension and bloating are frequent.
36
Communicable Disease Control
Diagnosis
Demonstration of Giardia lamblia cyst or trophozoite in
feces.
Treatment
1. Metronidazole or Tinidazole
3.3.5 Cholera
Definition
An acute illness caused by an enterotoxin elaborated by vibrio
cholerae.
37
Communicable Disease Control
Infectious agent
Vibrio cholerae
Epidemiology
Occurrence- has made periodic outbreaks in different parts of
the world and given rise to pandemics. Endemic
predominantly in children.
Reservoir- Humans
38
Communicable Disease Control
Clinical Manifestation
Abrupt painless watery diarrhea; the diarrhea looks like
rice water.
In severe cases, several liters of liquid may be lost in few
hours leading to shock.
Severely ill patients are cyanotic, have sunken eyes and
cheeks, scaphoid abdomen, poor skin turgor, and thready
or absent pulse.
Loss of fluid continues for 1-7 days.
Diagnosis
Based on clinical grounds
Culture (stool) confirmation
Treatment
1. Prompt replacement of fluids and electrolytes
Rapid IV infusions of large amounts
Isotonic saline solutions alternating with isotonic sodium
bicarbonate or sodium lactate.
2. Antibiotics like tetracycline dramatically reduce the duration
and volume of diarrhea resulting in early eradication of
vibrio cholerae.
Nursing care
1. Wear gown and glove.
2. Wash your hands.
39
Communicable Disease Control
Definition
An acute viral disease characterized by abrupt onset of fever,
malaise, anorexia, nausea and abdominal discomfort followed
within a few days by jaundice.
Infectious agent
Hepatitis A virus
Epidemiology
Occurrence- Worldwide distribution in sporadic and epidemic
forms. In developing countries, adults are usually immune and
40
Communicable Disease Control
Reservoir- Humans.
Mode of transmission- Person to person by fecal-oral route.
Through contaminated water and food contaminated by
infected food handlers.
Clinical manifestation
Abrupt onset of fever, malaise, anorexia, nausea and
abdominal discomfort, followed in few days by jaundice.
Complete recovery without sequel or recurrence as a rule.
Diagnosis
Based on clinical and epidemiological grounds
41
Communicable Disease Control
Treatment
Symptomatic: Rest, high carbohydrate diet with low fat and
protein.
42
Communicable Disease Control
3.4.1 Ascariasis
Definition
A helminthic infection of the small intestine generally
associated with few or no symptoms.
Infectious agent
Ascaris lumbricoides.
Epidemiology
Occurrence- The most common parasite of humans where
sanitation is poor. School children (5-10 years of age) are
most affected. Highly prevalent in moist tropical countries
43
Communicable Disease Control
Life Cycle
TRANSMISSION
1. Infective eggs ingested in
food or from contaminated
hands
ENVIRONMENT
6. Eggs become infective
(embryonated) in soil in 30-40
days.
7. Infective eggs contaminate the
environment.
HUMAN HOST
2. Larvae hatch.
Migrate through liver and lungs.
3. Pass up trachea and are swallowed
4. Become mature worms in small
intestine
5. Eggs produced and passed in
feces.
Fig. 3.4 Transmission and life cycle of Ascaris lumbricoides. (From Monica
Chesbrough, 1998, District Laboratory Practice in Tropical Countries, Part
One, Cambridge University Press, London.)
Clinical Manifestation
44
Communicable Disease Control
Diagnosis
Microscopic identification of eggs in a stool sample
Adult worms passed from anus, mouth or nose.
Treatment
1. Albendazole or
2. Mebendazole or
3. Piperazine or
4. Levamisole
3.4.2 Trichuriasis
Definition
A nematode infection of the large intestine, usually
asymptomatic in nature.
45
Communicable Disease Control
Infectious agent
Trichuris trichuria (whip worm)
Epidemiology
Occurrence- Worldwide, especially in warm moist regions.
Common in children 3-11 years of age.
Reservoir- Humans
46
Communicable Disease Control
Life Cycle
TRANSMISSION
1. Infective eggs ingested in food
or from contaminated hands
ENVIRONMENT
6. Eggs become infective
(embryonated) in soil after 3
weeks.
7. Infective eggs contaminate the
environment
HUMAN HOST
2. Larvae hatch.
Develop in small intestine.
Migrate to caecum.
3. Become mature worms.
4. Eggs produced and passed
in feces.
Fig. 3.5 Transmission and life cycle of Trichuris trichuria. (From Monica
Chesbrough, 1998, District Laboratory Practice in Tropical Countries, Part
One, Cambridge University Press, London.)
Clinical manifestation
Severity is directly related to the number of infecting
worms.
Most infected people are asymptomatic.
Abdominal pain, tiredness, nausea and vomiting, diarrhea
or constipation are complaints by patients.
Rectal prolapse may occur in heavily infected very young
children.
47
Communicable Disease Control
Diagnosis
Demonstration of eggs in feces.
Treatment
1. Albendazole or
2. Mebendazole
3.4.3 Entrobiasis
(Oxyuriasis, pinworm infection)
Definition
A common intestinal helminthic infection that is often
asymptomatic.
Infectious agent
Entrobius vermicularis
48
Communicable Disease Control
Epidemiology
Occurrence- Worldwide, affecting all socio-economic classes
with high rates in some areas. Prevalence is highest in
school-aged children, followed by preschools and is lowest in
adults except for mothers of infected children. Prevalence is
often high in domiciliary institutions. Infection usually occurs in
more than one family member.
Reservoir- Human
49
Communicable Disease Control
Life Cycle
Gravid females migrate through the
Adult worms anus to the perianal skin and
in Caecum deposit eggs (usually during the
night)
2-3 weeks
Eggs become infective in a few
hours in perianal area
Larvae
Migrate down
hatch in
To caecum Ingestion of eggs by Man
duodenum
Fig. 3.6 Transmission and life cycle of Entrobius vermicularis. (From Hegazi
st
M., 1994, Applied Human Parasitology, 1 edition, the Scientific Book
Centers, Cairo.)
Clinical manifestation
Perianal itching, disturbed sleep, irritability and some
times secondary infection of the scratched skin.
Diagnosis
Stool microscopy for eggs or female worms.
Treatment
1. Mebendazole.
50
Communicable Disease Control
3.4.4. Strongyloidiasis
Definition
An often asymptomatic helminthic infection of the duodenum
and upper jejunum.
Infectious agent
Strongyloides stercolaris
Epidemiology
Occurrence- In tropical and temperate areas. More common
in warm and wet regions.
Reservoir- Human
51
Communicable Disease Control
Life Cycle
TRANSMISSION
1. Infective filariform larvae
penetrate skin, e.g. feet.
Autoinfection also occurs.
ENVIRONMENT
6. In soil larvae become free-
living worms produce more
HUMAN HOST rhabditiform larvae*
2. Larvae migrate, pass up trachea * Free-living cycle can be
and are swallowed. repeated several times
3. Become mature worms in small 7. Become infective filariform
intestine larvae in the soil
4. Eggs laid. Hatch rhabditiform
larvae in intestine.
5. Rhabditiform larvae:
- Passed in feces, or
- Become filariform larvae in
intestine, causing
atutoinfection.
Clinical Manifestation
Pneumonia occurs during heavy larval migration.
Mild peptic ulcer like epigastric discomfort to severe
watery diarrhea.
Heavy infection may result in malabsorption syndrome.
Diagnosis
Identification of larvae in stool specimen.
52
Communicable Disease Control
Treatment
1. Albendazole or
2. Thiabendazole
Definition
A common chronic parasitic infection with a variety of
symptoms usually in proportion of the degree of anemia
Infectious agent
Ancylostoma duodenale and
Necator americanus
Epidemiology
Occurrence- Widely endemic in tropical and subtropical
countries where sanitary disposal of human feces is not
practiced and the soil moisture and temperature conditions
favor development of infective larvae.
Reservoir- Humans
53
Communicable Disease Control
Life cycle
TRANSMISSION
1. Infective filariform larvae penetrate the
skin, e.g. feet.
A. duodenale also transmitted by
ingestion of larvae.
ENVIRONMENT
5. Eggs develop; Rhabditiform
larvae hatch. Feed in soil.
6. Develop into infective filariform
HUMAN HOST larvae in about 1 week.
2. Larvae migrate. Pass up trachea 7. Filariform larvae contaminate soil.
and are swallowed.
3. Become mature worms in small
intestine (attach to wall and suck
blood).
4. Eggs produced and passed in
feces.
54
Communicable Disease Control
Clinical Manifestation
The clinical manifestation is related to:
1. Larval migration of the skin
Produces transient, localized maculopapular rash
associated with itching called ground itch.
2. Migration of larva to the lungs.
Produces cough, wheezing and transient pneumonitis.
3. Blood sucking
Light infection-no symptoms
Heavy infection-result in symptoms of peptic ulcer disease
like epigastric pain and tenderness. Further loss of blood
leads to anemia manifested by exertional dyspenea,
weakness and light-headedness.
Diagnosis
Demonstration of eggs in stool specimen.
Treatment
1. Mebendazole or
2. Albendazole or
3. Levamisole
55
Communicable Disease Control
3.5.1 Poliomyelitis
Definition
A viral infection most often recognized by the acute onset of
flaccid paralysis.
Infectious agent
Polio viruses (type I, II and III)
Epidemiology
Occurrence – Worldwide prior to the advent of immunization.
Cases of polio occur both sporadically and in epidemics.
Primarily a disease of infants and young children. 70-80% of
cases are less than three years of age. More than 90% of
infections are unapparent. Flaccid paralysis occurs in less
than 1% of infections.
56
Communicable Disease Control
Clinical manifestation
Usually asymptomatic or non-specific fever is manifested
in 90% of cases.
If it progresses to major illness, severe muscle pain, stiff
neck and back with or without flaccid paralysis may occur.
Paralysis is asymptomatic and occurs within three to four
days of illness.
The legs are more affected than other part of the body.
Paralysis of respiratory and swallowing muscles is life-
threatening.
Diagnosis
Based on clinical and epidemiological grounds
57
Communicable Disease Control
Treatment
Symptomatic
Definition
The tapeworm Echinococcus granulosus is the most common
species of Echinococcus and causes cystic hydatid disease.
Infectious agent
Echinococcus granulosus, a small tapeworm of dog
Epidemiology
Occurrence – occurs on all continents except Antarctica.
Especially common in grazing countries where dogs consume
viscera containing cysts.
58
Communicable Disease Control
Clinical manifestations
The signs and symptoms vary according to location of the
cyst and number.
Ruptured or leaking cysts can cause severe anaphylactic
reactions.
Cysts are typically spherical, thick walled and unilocular
and are most frequently found in the liver and lungs.
59
Communicable Disease Control
Diagnosis
History of residence in an endemic area along with
association with canines
Sonography and CT scan
Serologic test
Treatment
1. Surgical resection of isolated cysts is the most common
treatment.
2. Albendazol (mebendazol)
3. If cysts rupture, praziquantel
60
Communicable Disease Control
Review Questions
61
Communicable Disease Control
CHAPTER FOUR
AIR-BORNE DISEASES
4.2 Introduction
62
Communicable Disease Control
Droplets that are bigger in size will not remain air-borne for
long but will fall to the ground. Here, however, they dry and
mix with dust. When they contain pathogens that are able to
survive drying, these may become air-borne again by wind or
something stirring up the dust, and they can then be inhaled.
Air-borne diseases, obviously, will spread more easily when
there is overcrowding, as in overcrowded class rooms, public
transport, canteens, dance halls, and cinemas. Good
ventilation can do much to counteract the effects of
overcrowding. Air-borne diseases are mostly acquired through
the respiratory tract.
Definition
An acute catarrhal infection of the upper respiratory tract.
Infectious agent
Rhino viruses (100 serotypes) are the major causes in adults.
Parainfluenza viruses, respiratory syncytial viruses (RSV),
Influenza, and Adeno viruses cause common cold-like
illnesses in infants and children.
63
Communicable Disease Control
Epidemiology
Occurrence- Worldwide both in endemic and epidemic forms.
Many people have one to six colds per year. Greater
incidence in the highlands. Incidence is high in children under
5 years and gradually declines with increasing age.
Reservoir- Humans
Clinical Manifestation
Coryza, sneezing, lacrimation, pharyngeal or nasal
irritation, chills and malaise
Dry or painful throat.
64
Communicable Disease Control
Diagnosis
Based on clinical grounds
Treatment
1. No effective treatment but supportive measures like
:
Bed rest
Steam inhalation
High fluid intake
Anti pain
Balanced diet intake
Definition
An acute highly communicable viral disease
Infectious agent
Measles virus
65
Communicable Disease Control
Epidemiology
Occurrence- Prior to widespread immunization, measles was
common in childhood so that more than 90% of people had
been infected by age 20; few went through life without any
attack.
Reservoir- Humans
66
Communicable Disease Control
Clinical Manifestation
Prodromal fever, conjunctivitis, coryza, cough and Koplik
spots on the buccal mucosa
A characteristic red blotchy rash appears on the third to
seventh day, beginning on the face, gradually becoming
generalized, lasting 4-7 days.
Leucopoenia is common.
Complications like otitis media, pneumonia, diarrhea,
encephalitis, croup (Laryngo tracheo bronchitis) may
result from viral replication or bacterial super infection.
Diagnosis
Based on clinical and epidemiological grounds
Treatment
1. No specific treatment
2. Treatment of complications
3. Vitamin A provision
Nursing care
1. Advise patient to have bed rest.
2. Relief of fever.
3. Provision of non-irritant small frequent diet.
4. Shorten the fingernails.
67
Communicable Disease Control
4.5 Influenza
Definition
An acute viral disease of the respiratory tract
Infectious agent
Three types of influenza virus (A,B and C)
Epidemiology
Occurrence- In pandemics, epidemics and localized
outbreaks.
68
Communicable Disease Control
Clinical Manifestation
Fever, head ache, mayalgia, prostration, sore throat and
cough
Cough is often severe and protracted, but other
manifestations are self-limited with recovery in 2-7days
Diagnosis
Based on clinical ground
Treatment
1. Same as common cold, namely:
Anti-pain and antipyretic
High fluid intake
Bed rest
Balanced diet intake
69
Communicable Disease Control
4.6 Diphtheria
Definition
An acute bacterial disease involving primarily tonsils, pharynx,
nose, occasionally other mucus membranes or skin and
sometimes the conjunctiva or genitalia.
Infectious agent
Corynebacterium diphtheriae
Epidemiology
Occurrence- Disease of colder months in temperate zones,
involving primarily non-immunized children under 15 years of
age. It is often found among adult population groups whose
immunization was neglected. Unapparent, cutaneous and
wound diphtheria cases are much more common in the
tropics.
Reservoir- Humans
70
Communicable Disease Control
Clinical Manifestation
Characteristic lesion marked by a patch or patches of an
adherent grayish membrane with a surrounding
inflammation (pseudo membrane).
Throat is moderately sore in pharyngo tonsillar diphtheria,
with cervical lymph nodes somewhat enlarged and tender;
in severe cases, there is marked swelling and edema of
neck.
Late effects of absorption of toxin appearing after 2-6
weeks, including cranial and peripheral, motor and
sensory nerve palsies and myocarditis (which may occur
early) and are often severe.
71
Communicable Disease Control
Diagnosis
Based on clinical and epidemiological grounds
Bacteriologic examination of discharges from lesions.
Treatment
1. Diphtheria antitoxin
2. Erythromycin for 2 weeks but 1 week for cutaneous form
or
3. Procaine penicillin for 14 days or single dose of Benzathin
penicillin
72
Communicable Disease Control
Definition
An acute bacterial disease involving the respiratory tract.
Infectious agent
Bordetella pertusis
Epidemiology
Occurrence- An endemic disease common to children
especially young children everywhere in the world. A marked
decline has occurred in incidence and mortality rates during
the past four decades. Outbreaks occur periodically. Endemic
in developing world and 90% of attacks occur in children
under 6 yearsof age.
Reservoir- Humans
73
Communicable Disease Control
Clinical manifestation
The disease has insidious onset and 3 phases:
1. Catarrhal phase
Lasts 1-2 weeks
Cough and rhinorrhea
2. Paroxysmal phase
Explosive, repetitive and prolonged cough
Child usually vomits at the end of paroxysm
Expulsion of clear tenacious mucus often followed by
vomiting
Whoop (inspiratory whoop against closed glottis)
between paroxysms.
Child looks healthy between paroxysms
Paroxysm of cough interferes with nutrition and cough
Cyanosis and sub conjunctiva hemorrhage due to
violent cough.
74
Communicable Disease Control
3. Convalescent phase
The cough may diminish slowly or may last long time.
After improvement the disease may recur.
Diagnosis
Difficult to distinguish it from other URTI
History and physical examination at phase two
(paroxysmal phase) ensure the diagnosis.
Marked lymphocytosis.
Treatment
1. Erythromycin- to treat the infection in phase one but to
decrease transmission in phase two
2. Antibiotics for super infections like pneumonia because of
bacterial invasion due to damage to cilia.
Nursing care
1. Proper feeding of the child.
2. Encourage breastfeeding immediately after an attack
(each paroxysm).
3. Proper ventilation- continuous well humidified oxygen
administration.
4. Reassurance of the mother (care giver),
75
Communicable Disease Control
Definition
An acute bacterial infection of the lung tissue and bronchi.
Infectious agent
Streptococcus pneumoniae (pneumococcus)
Epidemiology
Occurrence- Endemic particularly in infancy, old age and
persons with underlying medical conditions. Epidemics can
occur in institutions, barracks and on board ship where people
are living and sleeping in close quarters. Common in lower
socio-economic groups and developing countries.
76
Communicable Disease Control
Clinical Manifestation
Sudden onset of chill, fever, pleural pain, dyspnea,
tachypnea, a cough productive of rusty sputum,
Chest indrawing, shallow and rapid respiration in infants
and young children.
Vomiting and convulsion may occur in infants and young
children.
77
Communicable Disease Control
Diagnosis
Based on clinical grounds
Chest X-ray- reveals consolidation of the affected lung
tissue but not in children.
Sputum gram stain- reveals gram negative diplococci
Treatment
1. Antipyretic and antipain
2. Antibiotics like Ampicillin or procaine penicillin for adults
but usually crystalline penicillin for children
3. Anticonvulsants for infants.
Nursing care
1. Monitor vital signs especially of children.
2. Maintain high body temperature to normal.
3. Intermittent administration of humidified oxygen if
indicated especially for young children.
4. Timely administration of ordered medication.
78
Communicable Disease Control
Definition
An acute bacterial disease that causes inflammation of the pia
and arachnoid space.
Infectious agent
Neisseria meningitides (the meningococcus)
Epidemiology
Occurrence- Greatest incidence occurs during winter and
spring. Epidemics occur irregularly. Common in children and
young adults. It is also common in crowded living conditions.
Reservoir- Humans
79
Communicable Disease Control
Clinical Manifestation
Sudden onset of fever, intense headache, nausea and
often vomiting, neck stiffness and frequently, petechial
rash with pink macules.
Kernig’s sign may be positive (i.e. patient feels back pain
when one of the lower limbs is flexed at the knee joint and
extended forward in an elevated position)
Brudinski’s sign may be positive (i.e. when the patient’s
neck is flexed, the two lower extremities get flexed or
raised up).
Delirium and coma often appear.
Diagnosis
Based on clinical and epidemiological grounds
White blood cell count. (neutrophils)
Cerebrospinal fluid analysis (Gram stain, white cell count,
etc.)
Treatment
1. Admit the patient and administer high dose of crystalline
penicillin intravenously
2. Antipyretic
Nursing care
1. Maintain fluid balance (input and output)
2. Maintain body temperature to normal
80
Communicable Disease Control
4.10 Tuberculosis
Definition
A chronic and infectious mycobacterial disease important as a
major cause of illness and death in many parts of the world.
Infectious agent.
Mycobacterium tuberculosis- human tubercle bacilli
(commonest cause)
Mycobacterium bovis- cattle and man infection
Mycobacterium avium- infection in birds and man.
81
Communicable Disease Control
Epidemiology
Occurrence- Worldwide, however underdeveloped areas are
more affected. Affects all ages and both sexes. Age groups
between 15-45 years are mainly affected. According to the
WHO 1995 report, 9 million cases and 3 million deaths have
occurred. According to the Ministry of Health report in 1993
E.C, tuberculosis was a leading cause of outpatient morbidity
(ranked 8th with 2.2%), leading cause of hospitalization
(ranked 3rd with 7.8%) and leading cause of hospital death
(ranked 1st with 10.1%). Tuberculosis has two major clinical
forms. Pulmonary (80%) primarily occurs during childhood
and secondarily 15-45 years or later. The other is extra
pulmonary, which affects all parts of the body. Most common
sites are lymph nodes, pleura, Genitourinary tract, bone and
joints, meninges and peritoneum.
82
Communicable Disease Control
Clinical Manifestation
Pulmonary tuberculosis
Persistent cough for 3 weeks or more
Productive cough with or without blood-stained sputum
Shortness of breath and chest pain
Intermittent fevers, night sweats, loss of weight, loss of
appetite, fatigue and malaise.
83
Communicable Disease Control
TB lymph adenitis
Slowly developing and painless enlargement of lymph
nodes followed by matting and drainage of pus.
Tuberculosis pleurisy
Pain while breathing in, dull lower chest pain, slight
cough, breathlessness on exertion.
Intestinal TB
Loss of weight and appetite
Abdominal pain, diarrhea and constipation
Mass in the abdomen
Fluid in the abdominal cavity (ascites)
Tuberculos meningitis
Headache, fever, vomiting, neck stiffness and mental
confusion of insidious onset.
Diagnosis
1. Clinical manifestations
2. Sputum smears for acid-fast bacilli (AFB), which is the
Golden standard. However, one positive result does not
84
Communicable Disease Control
Treatment
The following drugs are being used for treatment of TB in
Ethiopia.
Streptomycin (s) daily IM injection
Ethambutol(E)
Rifampin (R)
Thiacetazone (T)
Isoniazid (H)
Pyrazinamide (Z)
85
Communicable Disease Control
Nursing care
1. Educate the patient how and when to take the prescribed
medication.
2. Tell the patient not to stop the medication unless he/she is
told to do so.
3. Tell the patient to come to the health institution if he/she
develops drug side effects.
4. Advice the patient on the importance of taking adequate
and balanced diet and to eat what is available at home.
86
Communicable Disease Control
Definition
A chronic bacterial disease of the skin, peripheral nerves and,
in lepromatous patients, the upper airway
Infectious agent
Mycobacterium leprae
87
Communicable Disease Control
Epidemiology
Occurrence- Although common in rural tropics and
subtropics, socio-economic conditions may be more important
than climate itself. Endemic in south and southeast Asia,
tropical Africa and Latin America.
Reservoir- Humans
88
Communicable Disease Control
Clinical Manifestation
Clinical manifestations vary between two polar forms:
lepromatous and tuberculoid leprosy.
Borderline
Has features of both polar forms and is more liableto shift
toward the lepromatous form in untreated patients and toward
the tuberculoid form in treated patients.
89
Communicable Disease Control
Diagnosis
Complete skin examination (hyperesthesia, anesthesia,
paralysis, muscle wasting or trophic ulcer which are signs
of peripheral nerve involvement) with bilateral palpation of
peripheral nerves (ulnar nerve at the elbow, peroneal
nerve at head of fibula and the great auricular nerve) for
enlargement and tenderness.
Skin lesion are tested for sensation (light touch, pink
prick, temperature discrimination).
Demonstration of AFB in skin smears made by scraped
incision method.
Skin biopsy confined to the affected area should be sent
to the experienced pathologists in leprosy diagnosis.
Treatment
1. Dapsone three drugs for 12 months and then
2. Refampicin dapsone alone for the next 12 months.
3. Clfazamin
4. Aspirin for mild reactions and inflammation
5. Severe reaction can be treated with corticosteroids
90
Communicable Disease Control
Review Questions
91
Communicable Disease Control
CHAPTER FIVE
ARTHROPOD OR INTERMEDIATE
VECTOR-BORNE DISEASES
5.2 Introduction
92
Communicable Disease Control
5.3.1 Malaria
Definition
An acute infection of the blood caused by protozoa of the
genus plasmodium.
93
Communicable Disease Control
Infectious agent.
Plasmodium falciparum/malignant tertian: Invades all
ages of red blood cells. Red blood cell cycle is 48 hours
Plasmodium vivax/benign tertian: Invades reticulocytes
only. Red blood cell cycle is 48 hours.
Plamodium ovale/tertian: Invades reticulocytes only. Red
blood cell cycle is 48 hours.
Plasmodium Malariae/Quartan malaria: Invades
reticulocytes only. Red blood cell cycle is 72 hours.
Epidemiology
Occurrence- Endemic in tropical and sub-tropical countries of
the world. Affects 40% of the world population. Children less 5
years of age, pregnant women and travelers to endemic areas
are risk groups. Plasmodium falciparum 60% and vivax 40%
are common in Ethiopia.
94
Communicable Disease Control
Reservoir- Humans
95
Communicable Disease Control
Specific factors
This is a humoral and cell mediated immunity that is species
and strain specific, and hard-won after repeated infection.
Life cycle
TRANSMISSION
1. Sporozoites inoculated when Anopheles
mosquito takes a blood meal.
MOSQUITO
6. gametocytes ingested by
mosquito.
7. Male and female gametes
HUMAN HOST fuse. Zygote oocyst in
2. Sporozoites infect liver cells. Multiply stomach wall.
by schizogony. 8. Sporozoites form in oocyst.
Note: some sporozoites of P.vivax and 9. Oocyst ruptures.
p.ovale become dormant hypnozoites Sporozoites reach salivary
in liver. Become active after several glands of mosquito
months.
3. Liver schizonts rupture. Merozoites
enter red cells, become trophozites.
Multiply by schizogony.*
* with P. falciparum, schizogony
occurs in capillaries of body organs.
4. Schizonts rupture. Merozoites infect
new red cells.
5. Some merozoites develop into male
and female gametocytes.
Fig. 5.1 Transmission and life cycle of Malaria parasites. (From Monica
Chesbrough, 1998, District Laboratory Practice in Tropical Countries, Part
One, Cambridge University Press, London.)
96
Communicable Disease Control
Clinical Manifestation
Chills, rigor, fever, head ache, diarrhea, hallucinations,
abdominal pain, aches, renal or respiratory symptoms,
jaundice, etc.
Diagnosis
Clinical manifestation and epidemiological grounds
Blood film for hemoparasite
White blood cell count
Blood culture to rule out sepsis
Chest X-ray to rule out pneumonia.
Treatment
1. Plasmodium vivax, ovale and sensitive plasmodium
falciparum
Chloroquine or
Fansidar
2. Chloroquine resistant falciparum and when sensitivity
pattern is not known.
Quinine or
Fansidar
Nursing care
1. Advise patient to come back if the illness gets severe.
2. Advise on personal protection (bed nets, etc).
3. Reduce fever and maintain comfort.
97
Communicable Disease Control
Definition
A disease caused by the reaction of the body to the presence
of worms in the lymphatic system.
Infectious agent
Wucheriria bancrofti (vectors are culex, Anopheles and Aedes
species)
Brugia malayi and (vector is mansonia species)
Brugia timori (vector is Anopheles)
98
Communicable Disease Control
Epidemiology
Occurrence- Widely prevalent in tropical and subtropical
areas of Africa, Asia, Pacific Region, Central and South
America. Found in Gambella region (western Ethiopia).
99
Communicable Disease Control
Life cycle
TRANSMISSION
1. Infective larvae penetrate skin
when a mosquito takes a blood
meal.
MOSQUITO
4. Microfilariae ingested by
mosquito.
5. Microfilariae lose sheath.
Develop into infective larvae
in thoracic muscles.
HUMAN HOST* 6. Infective larvae (sheathed)
2.Larvae become adult worms migrate to mouth parts.
in the lymphatics.
3. Females produce sheathed
Microfilariae which pass into
blood.
* Animal hosts may be important for
B. Malayi.
Fig. 5.2 Transmission and life cycle of W. bancrofti and Brugia species (From
Monica Chesbrough, 1998, District Laboratory Practice in Tropical Countries,
Part One, Cambridge University Press, London.)
Clinical Manifestation
The presence of worms in the lymph vessels gives rise to a
foreign-body reaction. After the death of the worm, more
proteins are released; the reaction then is even more severe.
Three phases may be distinguished.
Acute phase:
Starts within a few months after infection
Lymphadenopathy
Fever
100
Communicable Disease Control
Eosinophilia
In this stage microfilariae are not demonstrable in the
peripheral blood because the worms are not yet mature.
The acute phase is mainly due to a hypersensitivity
reaction.
Subacute phase:
This occurs after about one year following acute phases.
In this phase worms have matured and micro filariae are
present in the peripheral blood.
Reactions to the adult worms cause attacks of fever with
lymphangitis, funiculitis or Epididymitis. Recurrent attacks
will sooner or later lead to hydrocele.
Lesions caused by microfilariae are less common and are
associated with hypereosinophilia and lung symptoms
(tropical pulmonary eosinophilia syndrome).
Chronic phase:
After many years of repeated attacks, lymph glands and
lymph vessels become obstructed; as a result lymph
edema develops. Lymph edema most commonly seen in
the legs or scrotum (elephantiasis) but may also be
present in vulva, breasts, or arms.
Since the adult worms have usually died, microfilariae are
not seen in the blood.
101
Communicable Disease Control
Diagnosis
Clinical and epidemiological grounds
Obstructive signs with history and travel to and
residence in endemic areas.
Best established by identifying microfilariae in the
peripheral blood (blood film).
Before taking blood sample one should know the
periodicity of microfilariae. That is, microfilariae appear in
the peripheral blood during the night (nocturnal) in most
parts of the world and during day (diurnal) in the South
Pacific region.
Single dose of Diethylcarbamazin Citrate (DEC) causes
the sequestered microfilariae to emerge to blood 45-60
minutes later. This test is said to be the mazoti test, which
is used in nocturnal periodicity.
102
Communicable Disease Control
Treatment
1. Diethyl carbamazin Citrate (DEC) results in rapid
disappearance of most microfilariae from blood but may
not destroy the adult worm. Because of this, we need to
repeat DEC annually for some years.
2. Refer the patient for surgical treatment of hydrocele.
Definition
An acute infectious viral disease of short duration and varying
severity.
Infectious agent
Yellow fever virus
Epidemiology
Occurrence- The disease exists in two transmission cycles.
Namely, the sylvatic or Jungle cycle, which occurs between
mosquitoes and non-human primates, and an urban cycle,
103
Communicable Disease Control
104
Communicable Disease Control
Clinical Manifestation
Typical attacks are characterized by sudden onset of
fever, chills, headache, backache, generalized pain,
prostration, nausea and vomiting.
Slow and weak pulse.
Bleeding tendency is common resulting in epistaxis,
bleeding of gums, hematemesis, melaena.
Jaundice occurs due to liver cell necrosis and this may
result in liver failure and death.
Albumin uria occurs due to nephrosis and this may result
in kidney failure and anuria.
Patients surviving the seventh day of the disease usually
recover.
Diagnosis
History of residence and/or travel to endemic area
Clinical manifestation
Treatment
No specific treatment.
Nursing care
1. Monitor vital signs regularly.
2. Maintain body temperature to normal.
3. Monitor input and output balance.
4. Keep patient in screened rooms or under mosquito nets to
avoid further infection.
105
Communicable Disease Control
5.4.1. Plague
Definition
A highly infectious bacterial disease which can kill many
people within a short time.
Infectious agent
Yersinia pestis, the plague bacillus.
Epidemiology
Occurrence- Endemic in wild rodents living in forests in the
highlands. Wild rodent plague exists in western USA, large
106
Communicable Disease Control
107
Communicable Disease Control
Clinical Manifestation
Bubonic plague- Characterized by swelling of lymph glands
(bubos); mostly the glands of the groins, sometimes arm pit or
other places. Swelling may be the size of an egg, tender or
non-tender. Other symptoms are:
Sudden high fever
Shock
Prostration
Coma
Death within 3-5 days
Pneumonic plague
Acute onset
Severe prostration
Watery sputum quickly followed by blood-stained sputum.
Pleural effusion
Death within 1-2 days
Diagnosis
Gram stain of sputum or pus-gram negative bacilli.
Treatment
1. Early treatment with antibiotics like streptomycin or
tetracycline or sulfa groups.
108
Communicable Disease Control
Definition
A rickettsial disease whose course resembles that of louse-
borne typhus, but is milder.
Infectious agent
Rickettsia typhi (Rickettsia mooseri)
Epidemiology
Occurrence- Worldwide, found in areas where people and
rats occupy the same buildings and where large numbers of
mice live. Occurs sporadically.
109
Communicable Disease Control
Clinical Manifestation
Prodromal symptoms of headache, myalgia, arthralgia,
nausea, and malaise developing 1 to 3 days before the
abrupt onset of chills and fever. Nearly all patients
experience nausea and vomiting early in the illness.
The duration of untreated illness averages 12 days.
Rash is present in only 13% of patients
Pulmonary involvement: non-productive cough and
pneumonia.
Diagnosis
Epidemiological ground
Weilfelix agglutination test (Serology)
110
Communicable Disease Control
Treatment
1. Doxycyclin or
2. Chloramphenicol
Definition
An acute rickettsial disease often with sudden onset.
Infectious agent
Rickettsia Prowazeki
Epidemiology
Occurrence- In colder areas where people may live under
unhygienic conditions and are louse-infected. Occurs
sporadically or in major epidemics, for example during wars or
famine, when personal hygiene deteriorates and body lice
flourish.
111
Communicable Disease Control
Clinical Manifestation
Early symptoms of fever, headache, mayalgia, macular
eruption appear on the body.
112
Communicable Disease Control
Diagnosis
Based on clinical and epidemiologic grounds
Serologic test (weil-felix agglutination test)
Treatment
1. Chloramphenicol or Tetracycline
Definition
An acute infectious bacterial disease characterized by
alternating febrile periods (recurrent pyrexial attacks).
113
Communicable Disease Control
Infectious agent
Borrelia recurrentis- cause of louse-borne relapsing fever
Borrelia duttoni-cause of tick-borne relapsing fever
Epidemiology
Occurrence- Occurs in Asia, eastern Africa (Ethiopia and
Sudan), the highland areas of central Africa and South
America. It occurs in epidemic form when it is spread by lice
and in endemic form when spread by ticks.
114
Communicable Disease Control
Clinical Manifestation
Sudden onset of illness with chills, fever and prostration,
headache, mayalgia and arthralgia
There may be nausea and vomiting, jaundice and liver
swelling.
After 4-5 days the temperature comes down, the patient stays
free for 8-12 days and then a relapse follows with the same
signs but less intense.
In untreated cases there may be up to ten relapses.
Diagnosis
Clinical and epidemiological grounds
Giemsa or Wright stain (blood film)
Dark field microscopy of fresh blood.
Treatment
1. Admit the patient.
2. Open vein (i.e. start iv-line) before administering penicillin.
3. Administer 400,000-600,000 IU procaine penicillin IM stat
4. Tetracycline during discharge for 3 days
5. Chloramphenicol in infants and children can be used in
place of tetracycline.
115
Communicable Disease Control
Nursing care
1. Maintain body temperature to normal.
2. Close vital sign monitoring for 3 hours after medication.
3. Check whether there is reaction or not and report.
4. Comfort the patient by providing antipain.
5. Shaving of hair, and delousing of clothes.
5.6.1 Schistosomiasis
Definition
It is a blood fluke (trematode) infection with adult worms living
within mesenteric or vesicle veins of the host over a life span
of many years.
116
Communicable Disease Control
Infectious agent
The major schistoma species that cause schistosomiasis of
humans are:
Schistosoma mansoni
Schistosoma Japonicum
Schistosoma Hematobium
Epidemiology
117
Communicable Disease Control
118
Communicable Disease Control
Life cycle
TRANSMISSION
1. Cercariae penetrate skin when
person in contact with contaminated
water
FRESH WATER
7. Eggs reach water.
Miracidia hatch
Snail host
8. Miracidia penetrate snail.
HUMAN HOST*
Become sporocysts and
2. Cercariae Î Schistosomula.
multiply (2 generations).
Migrate through lungs and
Sporocysts Î cercariae.
liver.
9. Cercariae leave snail.
3. Become mature flukes in
(S.Japonicum attaches to
portal venous system. Flukes
water vegetation).
pair.
4. Migrate to veins of lower large
intestine (S. haematobium to
veins of bladder)
5. Eggs laid in venules. Burrow
through into intestine (eggs of
S. haematobium into bladder)
6. Eggs passed in feces. (S.
haematobium in urine).
*S. japonicum also infects animals.
Fig. 5.3 Transmission and life cycle of Schistosoma species. (From Monica
Chesbrough, 1998, District Laboratory Practice in Tropical Countries, Part
One, Cambridge University Press, London.)
Clinical Manifestation
The stages of schistosomiasis are:
A. invasion
B. maturation
C. established infection and
D. late stage.
119
Communicable Disease Control
A. Invasion stage
Cercariae penetrate skin
Cercarial dermatitis with itching papules and local edema
Cercariae remain in skin for 5 days before they enter the
lymphatic system and reach the liver.
B. Maturation
Schistosoma mature in the liver.
Fever, eosinophilia, abdominal pain and transient
generalized urticaria (known as katayama syndrome)
Worms descend the portal vein. S. manson; migrates to
mesenteric veins in the intestinal wall and S.
haematobium to bladder plexus.
This stage may be diagnosed as clinical malaria or may
pass unnoticed.
C. Established infection
This is a stage of egg production and eggs reach to the
lumen of bladder and bowel.
Some eggs penetrate the tissue, reach the bladder and
intestinal wall are discharged with urine and feces.
Eggs that could not penetrate the tissue are carried with
blood to the liver and lungs.
Other eggs that fail to reach the lumen of the bladder or
bowel provoke an inflammatory reaction.
120
Communicable Disease Control
D. Late stage
This is the stage of fibrosis, which occurs where there are
eggs in the tissues. Around the bladder this may result in:
- Stricture of urethra leading to urine retention or fistula.
- Dilatation of ureters (hydroureter) and kidney
(hydronephrosis) possibly leading to kidney failure
- Calcification of bladder.
Diagnosis
Demonstration of ova in urine or feces,
Biopsy of urine and feces are repeatedly negative (rectal
snip, liver biopsy, bladder biopsy).
Treatment
121
Communicable Disease Control
Definition
An infection of the subcutaneous and deeper tissues by large
nematode.
122
Communicable Disease Control
Infections agent
Dracunculus medinensis, a nematode
Epidemiology
Occurrence- In Africa (16 countries south of the Sahara) and
in Asia (India and Yemen) especially in regions with dry
climates. Local prevalence varies greatly. In some locales,
nearly all inhabitants are infected, in others, few, mainly young
adults.
Reservoir- Humans
123
Communicable Disease Control
Clinical Manifestation
Few or no clinical manifestations are evident until just
before the blister forms.
Fever and generalized allergic symptoms, including
periorbital edema, wheezing, and urticaria.
The emergence of the worm is associated with local pain
and swelling.
When the blister ruptures, the adult worm releases larva-
rich fluid and this is associated with a relief of symptoms.
The shallow ulcer surrounding the emerging adult worm
heals over weeks to months.
Diagnosis
Based on clinical and epidemiological grounds
124
Communicable Disease Control
Treatment
1. Gradual extraction of the worm by winding of a few
centimeters on a stick each day remains the common and
effective practice. Worms may be excised surgically.
2. Administration of thiabendazole or metronidazol may
relive symptoms but has no proven activity against the
worm.
125
Communicable Disease Control
Review Questions
126
Communicable Disease Control
CHAPTER SIX
SEXUALLY TRANSMITTED
DISEASES
6.2. Introduction
127
Communicable Disease Control
128
Communicable Disease Control
Definition
A disease characterized by a primary lesion, a later
secondary eruption on the skin and mucus membranes, then
a long period of latency, and finally late lesions of skin, bones,
viscera, CNS and cardiovascular systems.
Infectious agent
Treponema pallidum, a spirochete.
Epidemiology
Occurrence: Worldwide spread. Primarily involving sexually
active young people between 20 and 29 years. More common
in urban than rural areas.
Reservoir - Humans
129
Communicable Disease Control
Clinical Manifestation
The clinical presentation is divided into three groups:
a) Primary syphilis – consists of hard chancre, the primary
lesion of syphilis, together with regional lymphadenitis.
The hard chancre is a single, painless ulcer on the
genitalia or elsewhere (lips, tongue, breasts) and heals
spontaneously in a few weeks without treatment.
130
Communicable Disease Control
Diagnosis
Serological test – will be positive 6 to 8 weeks after
infection
Dark field microscopy of smears from primary lesion
(hard chancre) or from skin lesions in the early secondary
stage will show the spirochaetes.
131
Communicable Disease Control
Treatment
1. Primary and secondary syphilis
Benzathin penicillin 2.4 M IU Im stat or
Tetracycline or Erythromycin 500mg PO Qid for 2
weeks for penicillin sensitive people
2. Tertiary syphilis
Benzathin penicillin 2.4 M IU Im single dose every
week for 3 consecutive weeks or
Tetracycline or Erythromycin for one month for
penicillin sensitive individuals.
132
Communicable Disease Control
Definition
An acute bacteria infection localized in the genital area and
characterized clinically by single or multiple painful narcotizing
ulcers at the site of infection.
Infectious agent.
Haemophilus ducreyi, the Ducrey bacillus
Epidemiology
Occurrence – endemic in many developing countries. The
commonest cause of genital ulcer in many developing
counties. Most frequently diagnosed in men, especially those
who frequently prostitutes.
Reservoir – Humans
133
Communicable Disease Control
Clinical manifestation
Classic Chancroid ulcer begins as a tender papule
that ulcerates within 24 hours.
The ulcer is painful, irregular and sharply demarcated
from the nearby skin.
About 50% of men will have single ulcer.
Diagnosis
Clinical, but always rule out syphilis
Gram stain of smear from ulcer shows typical rods in
chain
Culture.
Treatment
1. Co- trimorazele or
2. Erythromycin or
3. Tetracycline can be used
N.B. Do not incise lymph nodes even with fluctuation because
they will completely heal with treatment.
134
Communicable Disease Control
Definition
A venereal disease caused by chlamydia microorganisms,
most commonly manifested by acute inguinal lymph adenitis.
Infectious agent
Chlamydia trachomatis (Ll L2 and L3)
Epidemiology
Occurrence – Common in most parts of the world but very
common in tropical and subtropical regions of Africa and Asia.
Its incidence is more common in males than females, and is
lower than Gonorrhea and Chancroid.
135
Communicable Disease Control
Clinical manifestation
Lymph adenopathy with non-specific symptoms of fever,
chills, head ache, malaise, anorexia and weight loss.
Regional lymph nodes undergo suppuration followed by
extension of inflammatory process to the adjacent tissues.
In the female, inguinal nodes are less frequently affected
and involvement is mainly of the pelvic nodes with
extension to the rectum and recto vaginal septum,
resulting in proctitis, stricture of the rectum and fistula.
Elepthantiasis of genitalia, scrotum and vulva occur in
either sex.
Diagnosis
Clinical presentation (i.e. presence of bubo.)
Culture of bubo aspirate.
136
Communicable Disease Control
Treatment
1. Tetracycline or
2. Erythromycin or
3. Co -trimoxazole can be used
4. Aspiration of fluctuating bubo and wound care
Definition
A viral infection characterized by a localized primary lesion,
latency and a tendency to localized recurrence.
Infectious agent
Herpes simplex virus (HSv) type 2
Epidemiology
Occurrence – worldwide. HSV 2 infection usually begins with
sexual activity and is rare before adolescence, except in
sexually abused children. Prevalence is greater (up to 60%) in
137
Communicable Disease Control
Reservoir – Humans.
Clinical manifestation
First – episode primary genital herpes is characterized by
fever, head ache, malaise and myalgias
Pain, itching, dysuria, vaginal and urethral discharge, and
tender inguinal lymph adenopthy are the predominant
local symptoms.
138
Communicable Disease Control
Treatment
1. Oral acyclovir is effective
6.7 Candidiasis
Definition
A mycosis usually confined to the superficial layers of skin or
mucus membranes, presenting clinically as oral thrush or
vulvovaginitis.
Infectious agent
Candida albicans (most common cause)
Candida tropicalis (rare cause)
139
Communicable Disease Control
Epidemiology
Occurrence – Worldwide. Candida albicans is often part of
the normal human flora.
Reservoirs – Humans
Clinical manifestation
Severe vulvar pruritis (prominent feature)
vaginal discharge (scanty, whitish, yellow, thick to form
curds, non-offensive)
sore vulva due to itching
speculum examination – thick whitish plugs attached to
vaginal wall
140
Communicable Disease Control
Diagnosis
Based on clinical grounds
Microscopic demonstration of pseudohyphae or yeast
cells in infected tissue or body fluids (vaginal discharge)
Culture (vaginal discharge)
Treatment
1. Nystatine vaginal pessary or
2. Miconazole or clotrmazele creams or
3. Keto conazole or
4. Fluconazele in recurrent cases
6.8 Gonorrhea
Definition
An acute or chronic purulent infection of the urogenital tract.
Infectious agent
Neisseria gonorrhea, the gonococcus
141
Communicable Disease Control
Epidemiology
Occurrence – worldwide, affecting both genders, especially
sexually active adolescents and young adults. Common in
rural areas. Prevalent in communities of lower socio-economic
status. In most industrialized countries, the incidence has
decreased during the past two decades.
Clinical manifestations
Males- Usually involves the urethra resulting in purulent
discharge, dysurea and frequency.
142
Communicable Disease Control
Diagnosis
Gram stain of discharge (urethral, cervical, conjuctival
discharge)
Culture on selective media
Treatment
1. Co - trimoxazole or
2. Erythromycin or
3. Ceftriaxone can be used
6.9 Trichomoniasis
Definition
A common and persistent protozoal disease of the genito-
urinary tract.
Infectious agent
Trichomonas vaginalis, a flagellate protozoan
143
Communicable Disease Control
Epidemiology
Occurrence - worldwide spread, a frequent disease of all
continents and all races, primarily of adults, with the highest
incidence among females 16 - 35 years. Overall, about 20%
of females may become infected during their reproductive
years.
Reservoir - Humans.
Clinical manifestation
Most men remain asymptomatic although some develop
arthritis, and a few have epididymitis or prostatitis.
144
Communicable Disease Control
Diagnosis
Detection of motile trichomonads by microscopy of wet
mounts of vaginal or prostatic secretions remains the
conventional means of diagnosis.
Culture (most effective) takes 3 - 7 days.
Treatment.
1. Metronidazole or
2. Clotrimazole vaginal suppository for pregnant women
cures up to 50%.
145
Communicable Disease Control
6.10 HIV/AIDS
Definition
A severe, life - threatening clinical condition, first recognized
as a distinct syndrome in 1981. This syndrome represents the
late clinical stage of infection with the human immuno-
deficiency virus (HIV), which most often results in progressive
damage to the immune and other organ systems, including
the CNS.
Infections agent
Human immuno-deficiency virus (HIV) (HIV-1 and HIV-2 )
Epidemiology
Occurrence - worldwide spread pandemic. HIV -1 infections
are now distributed worldwide, but are most prevalent in Sub-
Saharan Africa, the Americas, western Europe and southern
and Southeast Asia. HIV -2 has been found primarily in West
Africa, with some cases in the western hemisphere and other
African countries that are linked epidemiological to West
Africa.
146
Communicable Disease Control
Reservoir - Humans
147
Communicable Disease Control
Clinical manifestations
Acute HIV syndrome. Occurs 3 - 6 weeks after primary
infection. Clinical findings in the acute syndrome are: fever,
pharyngitis, lymphadenopathy, head ache, retro-orbital pain,
arthralgias, myalgias, lethargy or malaise, anorexia, weight
loss, nausea or vomiting or diarrhea. Meningitis, Encephalitis,
peripheral neuropathy, myopathy, erythematous
maculopupular rash, mucocutaneous ulceration.
Diagnosis
Based on clinical ground in the late stage
Based on serologic test in the early and late stage
148
Communicable Disease Control
Treatment
1. No specific treatment.
2. Treatment of opportunistic infections.
3. Use of anti-HIV drug to reduce transmission of the virus to
the fetus of pregnant mothers reduces fetal infection.
149
Communicable Disease Control
Review Questions
150
Communicable Disease Control
CHAPTER SEVEN
ZOONOTIC DISEASES
7.2 Introduction
151
Communicable Disease Control
7.3.1Taeniasis
Definition
Taeniasis is an intestinal infection with the adult stage of large
tapeworms. Cysticercosis is a tissue infection with the larval
stage.
Infectious agent
Taenia saginata (beef tapeworm)
Taenia solium (pork tapeworm)
Epidemiology
Occurrence- Worldwide; frequent where beef or pork is eaten
raw or insufficiently cooked and where sanitary conditions
permit pigs and cattle to have access to human feces.
Prevalent in Latin America, Africa, South East Asia and
Eastern Europe.
152
Communicable Disease Control
153
Communicable Disease Control
Life cycle
TRANSMISSION
1. Cysticerci ingested in
undercooked meat. T. saginata
in beef T. solium in pork.
ENVIRONMENT
6. Segments and eggs reach ground
where animals feed.
Animal host:
Cattle for T. saginata pig for T. solium
7. Eggs ingested.
8. Embryos carried to muscles. Develop
into infective cysticerci.
HUMAN HOST
2. Cysticerci attached to wall of
small intestine.
3. Become mature tapeworms
4. Eggs released when gravid
segments become
detached.
5. Eggs and gravid segments
passed in feces.
Fig.7.1 Transmission and life cycle of Taenia solium and Taenia saginata.
(From Monica Chesbrough, 1998, District laboratory practice in tropical
countries, part one, Cambridge University press, London.)
154
Communicable Disease Control
Diagnosis
Identification of proglottidis (segments)
Eggs in feces or anal swab
Cysticercus – palpable subcutaneous cysticercus and
microscopic examination of an excised cysticercus
confirms the diagnosis.
Intracerebral and other tissues- CT scan, MRI or by x-ray
when the cysticerci are calcified.
Treatment
1. Single dose of praziqantel is highly effective or
2. Niclosamide or
3. Dechlorophil or
155
Communicable Disease Control
4. Mebendazole or
5. Albendazole
T. Solium
Treatment is the same as to T. saginata but praziqantel
can evoke an inflammatory response in the CNS if cryptic
cysticercosis is present.
Cysticercosis management
- Chemotherapy
- Surgery and supportive medical treatment
For symptomatic patients with neurocysticercosis,
admission is required. Combination of Praziquantel and
Albendazole can be used. Besides, high dose of
glucocorticoids can be used to decrease inflammation.
156
Communicable Disease Control
7.3.2 Brucellosis
Definition
A systemic bacterial disease with acute or insidious onset
transmitted to humans from infected animals.
Infectious agent
Brucella melitensis (most common worldwide), acquired
primarily from goats, sheep and camels.
B. abortus from cattle
B. suis from pigs
B. canis from dogs
These are small aerobic gram-negative bacilli, intracellular
parasites.
Epidemiology
Occurrence- Worldwide. Predominantly an occupational
disease of those working with infected animals or their tissues
especially farm workers, veterinarians and abattoir workers,
which is more frequent among males. Outbreaks can occur
among consumers of raw milk and milk products, especially
unpasteurized soft cheese from cows, sheep and goats.
157
Communicable Disease Control
Clinical manifestation
Abrupt onset of symptoms
Most common symptoms are: Fever, chills, diaphoresis,
headache, myalgia, fatigue, anorexia, joint and low back
pain, weight loss, constipation, sore throat, and dry
cough.
Physical examination reveals
- Often no abnormalities and patient looks well
158
Communicable Disease Control
Diagnosis
Exposure and consistent clinical features
Serology- raised levels of B. agglutinin
Blood or bone marrow culture
Treatments
Doxycyline + aminogrycoside for 2 weeks followed by
Doxycycline + Rifampcin for 4-8 weeks is the most
effective regimen.
In pregnancy and in children less than 7 years, Bacterium
and Rifapcin for 8-12 weeks
N:B 4-14 days after the initiation of therapy, patients become
afebrile and constitutional symptoms disappear but enlarged
liver and spleen return to normal size within 2-4 weeks.
159
Communicable Disease Control
Definition
A disease caused by an intestinal round worm whose larvae
(trichinae) migrate to and become encapsulated in the
muscles.
Infectious agent
Trichinella spiralis, an intestinal nematode
Epidemiology
Occurrence - Worldwide, but variable incidence, depending
in part on practices of eating and preparing pork or wild
animal meat.
160
Communicable Disease Control
Clinical manifestation
Symptoms result from invasion of the body by larvae
produced by the adult female worm in the intestine and
from their encystment in striated muscles.
Infection ranges from symptomatic to mild febrile illness to
a severe progressive illness with multiple system
involvement.
Fever (low - high grade)
Muscle pain mainly upon movement
Edema, and spasm (periorbital and facial)
Photophobia and conjunctivitis
161
Communicable Disease Control
Weakness or prostration
Pain on swallowing
Dyspnea, coughing and hoarseness
Subconjuctival, retinal and nail splinter hemorrhage and
rashes
Diarrhea
Abdominal cramps
Nausea and vomiting
Diagnosis
History of ingestion of raw or inadequately cooked pork
Larvae in muscle biopsy
Positive serologic test
Eosinophilia
Treatment
1. Hospitalization of the patient
2. Mebendazole or
162
Communicable Disease Control
3. Albendazole or
4. Thiabendazole
5. High doses of corticosteroids for 1-2 days followed by
lower doses for several days or weeks. But not for
intestinal stage.
7.3.4 Toxoplasmosis
Definition
Toxoplasmosis is a systemic protozoal disease that can be
either acute or chronic type with intracellular parasite.
Infectious agent
Toxoplasma gondii
163
Communicable Disease Control
Epidemiology
Occurrence- Worldwide in mammals and birds. Infection in
man is common. In the United States and most European
countries, the prevalence of sero-conversion increases with
age and exposure. In Central America, France, Turkey and
Brazil, sero-prevalence is much higher, approaching 90% by
age of 40.
There are five main developmental forms in the life cycle, but
only trophozoites and cyst stages are found in human. All
stages occur in the felines (cats).
164
Communicable Disease Control
Mood of Transmission
1. Ingestion of cysts in raw or under-cooked meat
2. Ingestion of oocysts in food, drink or from hands
contaminated with feces of an infected cat.
3. Transplacental/congenital
4. Blood transfusion
5. Organ transplantation
165
Communicable Disease Control
Clinical manifestation
166
Communicable Disease Control
Diagnosis
Clinical sign and symptom
Serological test
Demonstration of the agent in body fluid or tissue biopsy
cell culture
Treatment
1. Treatment is not routinely indicated for a healthy immuno-
competent host, except in an initial infection during
pregnancy or the presence of active choreoretinitis and
myocarditis or other organ involvement.
2. The preferred treatment for those with severe
symptomatic disease is: Pyrimethamine combined with
sufadiazine and folinic acid for four weeks.
3. For pregnant women, Spirmycin is commonly used to
prevent placental infection. If ultrasound or other studies
indicate that fetal infection has occurred, Pyrimethamine
and sulfadiazine should be considered.
167
Communicable Disease Control
168
Communicable Disease Control
7.4.1 Rabies
Definition
It is almost invariably fatal: acute vial encephalomyelitis
(attacking brain and meninges).
Infectious agent
Rabies virus
Epidemiology
Occurrence- Worldwide in wildlife particularly in developing
countries. It is primarily a disease of animals (zoonotic). It is
primarily an infection of carnivores transmitted through bite.
169
Communicable Disease Control
Clinical Manifestation
The clinical manifestation, which is the same in all species
including humans, has 3 phases:
Prodromal phase
Excitatory phase
Paralytic phase
170
Communicable Disease Control
Diagnosis
History of bite by known rabid animal and the bitten
person show typical symptoms leading to clinical
diagnosis.
Treatment
1. Wound Care
Wash the wound with soap and water thoroughly to
decrease the viral load.
If there is bleeding cover the wound.
Never suture the wound as this will spread the virus.
2. Start anti-rabies vaccine immediately if it is proved to be
rabid animal bite.
171
Communicable Disease Control
7.5.1 Anthrax
Definition
An acute bacterial disease usually affecting the skin, but
which may very rarely involve the oropharynx, lower
respiratory tract, mediastinum or intestinal tract.
Infectious agent
Bacillus anthracis, spore forming bacteria.
Epidemiology:
Occurrence- Worldwide. Primarily a disease of herbivores.
Humans and carnivores are incidental hosts. Primarily an
occupational hazard of workers who process hides, hair
(especially from goats), bone and bone products and wool:
and of veterinarians and agriculture and wildlife workers who
handle infected animals. Human anthrax is common
(endemic) in those agricultural regions of the world where
anthrax in animals is common, including countries in South
and Central America, southern and eastern Europe, Asia and
Africa.
172
Communicable Disease Control
Mode of transmission-
Cutaneous anthrax: Contact with tissues of animals
(Cattle, sheep, goats, horses, pigs and others) dying of
the disease. Bite of flies that had partially fed on such
animals, contaminated hair, wool, hides, or products
made from them such as drums or brushes or contact
with soil associated with infected animals.
Inhalation anthrax: inhalation of spores in risky industrial
processes such as tanning of hides, or wool or bone
processing, where aerosols of B. antracis spores may be
produced.
Intestinal and oropharyngeal anthrax: ingestion of
contaminated meat; but there is no evidence that milk
from infected animals transmits anthrax.
173
Communicable Disease Control
Clinical manifestation
Cutaneous Anthrax
Approximately 95% of human cases of anthrax are
cutaneous form and about 5% are the inhalation form.
Found on exposed areas of skin (head, neck, face and
hands).
Small red macules appear.
Lesion- progress to papule, vesicle or pustule during the
next week and formation of an ulcer with blackened
necrotic eschar surrounded by a highly characteristic,
expanding zone of brawny edema.
174
Communicable Disease Control
Inhalation anthrax
Presentation of symptoms of severe viral respiratory
diseases makes early diagnosis difficult.
Acute phase supervenes after 1-3 days. With increasing
fever, dyspnea, stridor, hypoxia, and hypotension usually
leading to death within 24 hours.
175
Communicable Disease Control
Oropharyngeal anthrax
Fever, sore throat, dysphagia, painful regional
lymphadenopathy toxemia, respiratory distress may be
evident.
The primary lesion is most often on the tonsils.
Diagnosis
Clinical data
Gram stain of wound discharge
Culture from the wound discharge or blood
Treatment
For Cutaneous anthrax
1. Penicillin-G IV until edema subsides and with subsequent
oral penicillin to complete the course (adults). For
Penicillin-sensitive adults, Ciprofloxacin, erythromycin,
Tetracycline, Chloramphenicol can be substituted.
2. Clean and cover the cutaneous lesions.
176
Communicable Disease Control
7.6.1 Leishmaniasis
Definition
A polymorphic protozoan disease of the skin and mucous
membrane or a chronic systemic disease caused by a number
of species of the genus leishmania.
Infectious agents
For cutaneous and mucosal Leishmaniasis
Leishmania tropica Leishmania donovani *
Leishmania major and Leishmania infantum *
Leishmania aethiopica*
177
Communicable Disease Control
Epidemiology
Occurrence- It occurs in Pakistan, India and recently China,
the Middle East including Iran and Afghanistan, southern
regions of the former Soviet Union, sub-Saharan Africa,
Sudan, the highlands of Ethiopia, Kenya and Namibia. Urban
populations including children may be at risk. In the developed
world, the disease is restricted to occupational groups, such
as those involved in work in forest areas; to those whose
homes are in or next to a forest and to visitors to such areas
from non-endemic countries. It is common where dog
populations are high, generally more common in rural than
urban areas.
178
Communicable Disease Control
Life cycle
TRANSMISSION
1. Promastigotes injected
through skin when sand fly
takes a blood meal
SANDFLY
3. Amastigotes ingested by sand fly.
4. Amastigotes become promastigotes.
5. Promastigotes multiply. Migrate to
head and mouth parts of fly.
HUMAN HOST*
2. Promastigotes taken up by
macrophages. Become amastigotes
Multiply in reticuloendothelial cells (VL)
or skin macrophages (CL, MCL).
* Leishmania species infect a wide
range of animals.
Fig. 7.2 Transmission and life cycle of Leishmania parasites VL: Visceral
leishmaniasis, CL: Cutaneous leishmaniasis MCL: Mucocutaneous
leishmaniasis. (From Monica Chesbrough, 1998, District Laboratory Practice
in Tropical Countries, Part One, Cambridge University Press, London.)
179
Communicable Disease Control
Clinical Manifestation
There are papules that further develop to ulcers. The
disease is characterized by fever, hepathosplenomegally,
lymphadenopathy, anemia, leucopoenia, thrombocy-
topenea, and progressive emaciation and weakness.
Diagnosis
Demonstration of the parasite (blood or tissue)
By culture of the motile promastigote
Using serologic test
Treatment
Pentalvalent antimonial agents
Pentamidine or
Amphotercin or
Aminoglycoside aminosidine or
Cytokine immunotherapy
180
Communicable Disease Control
Definition
A systemic disease caused by protozoa characterized by
fever followed by general weakness and cerebral involvement
leading to death.
Infectious agent
The commonest agents are:
T. Brucei rhodesiense
T. Brucei gambiense
Other species which are less important are;
T. Cruzi, which causes American Trypanosoniasis
Vectors for all species are tsetse flies of Genus Glossina.
Epidemiology
Occurrence-The trypanosomes that cause sleeping sickness
are found only in Africa. 20,000 new cases are reported each
year. This number surely under-estimates the true incidence.
T. brucei gambiense occurs and is widely distributed in the
tropical rainforests of Central and West Africa. Gambiense
trypanosomes are primarily a problem in rural population;
tourists rarely become infected. The principal reservoir of T.B
rhodesiense in savanna and woodland areas of Central and
East Africa are Trypotolerant antelope species. Humans
acquire T.B. rhodesiense infection only incidentally while
181
Communicable Disease Control
182
Communicable Disease Control
Life cycle
TRANSMISSION
1. Trypomastigotes injected
through skin when tsetse fly
takes a blood meal
TSETSEFLY
3. Trypomastigotes ingested by tsetse
fly
4. parasites multiply in mid gut.
Migrate to salivary glands.
5. Become epimastigotes and multiply.
Develop into infective metacyclic
HUMAN HOST* trypomastigotes.
2. Trypomastigotes multiply
in blood. Lymph and in
later stages. In CNS.
* T.b. rhodesiense infects a
wide range of game
animals and domestic
animals.
Fig. 7.3 Transmission and life cycle of T.b. rhodesiense and T.b gambiense.
(From Monica Chesbrough, 1998, District Laboratory Practice in Tropical
Countries, Part One, Cambridge University Press, London.)
Clinical Manifestation
183
Communicable Disease Control
6. Malaise
7. Headache
8. Weight loss
9. Edema
10. Hepatomegally and
11. Tachycardia
Stage II
1. Abnormality in CSF
2. Day time somnolence
3. Tremors
4. Parkinson’s disease may appear
5. Hypertonia
6. Congestive heart failure
7. CNS disease develops
8. Coma and death
Diagnosis
Wet blood smear
Thick blood smear
Serological test
CSF analysis
Blood film
Bone marrow biopsy
184
Communicable Disease Control
Treatment
1. Pentamidine or
2. Etlornithine or
3. Helarsupron or
4. Trypansamide
These are drugs to be used for treatment of different stages.
For stage II
Trypansamide
185
Communicable Disease Control
186
Communicable Disease Control
Review Questions
187
Communicable Disease Control
CHAPTER EIGHT
8.2 Introduction
188
Communicable Disease Control
Definition
An intoxication (not infection) of abrupt and sometimes violent
onset.
Epidemiology
Occurrence- Widespread and relatively frequent
189
Communicable Disease Control
Clinical Manifestation
Sudden onset of vomiting and watery diarrhea
Fever and abdominal cramp
The intensity of illness may require hospitalization.
Diagnosis
Group of cases with characteristic acute predominantly
upper gastrointestinal symptoms and the short interval
190
Communicable Disease Control
Treatment
1. Fluid and electrolyte replacement if fluid loss is significant
particularly in severe cases.
191
Communicable Disease Control
8.4 Botulism
Definition
A paralytic disease that begins with cranial nerve involvement
and progresses caudally to involve the extremities.
Epidemiology
Occurrence- Worldwide occurrence. Home-canned foods,
particularly vegetables, fruits and less commonly with meat
and fish. Outbreaks have occurred from contamination
through cans damaged after processing. Commercial
products occasionally cause outbreaks but some of these
outbreaks have resulted from improper handling after
purchase. Food-borne botulism can occur when a food to be
preserved is contaminated with spores.
192
Communicable Disease Control
Clinical Manifestations
Illness varies from a mild condition to very severe disease
that can result in death within 24 hours.
Symmetric descending paralysis is characteristic and can
lead to respiratory failure and death.
Cranial nerve involvement marks the onset of symptoms;
usually produces diplopia, dysphagia. Weakness
progresses, often rapidly, from the head to involve the
neck, arms, thorax and legs; the weakness is occasionally
asymmetric.
Nausea, vomiting, abdominal pain may proceed or follow
the onset of paralysis.
Dizziness, blurred vision, dry mouth, and occasionally
sore throat are common.
No fever
Ptosis is frequent.
Papillary reflexes may be depressed: fixed or dilated
pupils are noted in half of patients.
193
Communicable Disease Control
Diagnosis
Clinical- afebrile, mentally intact patients who have
symmetric descending paralysis without sensory findings.
Appropriate History.
Demonstration of organisms or its toxin in vomitus, gastric
fluid or stool is strongly suggestive of the diagnosis
Wound culture
Treatment
1. Hospitalize the patient and monitor closely.
3. Intubation and mechanical ventilation may be needed.
4. Antitoxin administration after hypersensitivity test to horse
serum.
5. Emesis and lavage if short time after ingestion of food to
decrease the toxin.
194
Communicable Disease Control
8.5 Salmonellosis
Definition
A bacterial disease commonly manifested by an acute
enterocolitis.
Infectious agent
Salmonella typhimurium and Salmonella enteritidis are the
two most commonly reported.
Epidemiology:
Occurrence- Worldwide
195
Communicable Disease Control
Clinical manifestation
Self limited fever and diarrhea (bloody or dysenteric when
colon is involved)
Nausea, vomiting and abdominal cramp
Microscopic leukocytosis.
Diagnosis
Blood culture initially
Stool, culture
196
Communicable Disease Control
Treatment
1. Symptomatic
2. If there is an underlying immunosuppressive disease
(conditions like AIDS, lymphoma, immunosuppressive
treatment), treat the underlying cause.
197
Communicable Disease Control
Review Questions
198
Communicable Disease Control
CHAPTER NINE
NURSING RESPONSIBILITIES IN
THE MANAGEMENT OF
COMMUNICABLE DISEASES
199
Communicable Disease Control
200
Communicable Disease Control
201
Communicable Disease Control
202
Communicable Disease Control
203
Communicable Disease Control
204
Communicable Disease Control
Review Questions
205
Communicable Disease Control
GLOSSARY
206
Communicable Disease Control
207
Communicable Disease Control
208
Communicable Disease Control
209
Communicable Disease Control
210
Communicable Disease Control
References
211
Communicable Disease Control
212